相关实验视频
Updated: Jul 24, 2025
03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
492
外体PIK3CB在食道状细胞癌中促进PD-L1表达和恶性转变
Wei Xu1, Yang Chen1, Zhi Zhang1
1Department of Thoracic Surgery, Chongqing University Cancer Hospital, Chongqing, China.
Medical oncology (Northwood, London, England)
|July 4, 2023
概括
在食道状细胞癌 (ESCC) 患者中,外体PIK3CB蛋白的高水平与预后不佳相关. 向外体PIK3CB可能为ESCC提供新的诊断和治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 食道状细胞癌 (ESCC) 的5年生存率很低,需要对其机制和治疗方法进行研究.
- 了解ESCC攻击性和治疗耐药性的分子驱动因素至关重要.
研究的目的:
- 调查外体PIK3CB在ESCC中的作用.
- 探索ESCC中外体PIK3CB,PD-L1表达和上皮-介质细胞过渡 (EMT) 之间的关系.
- 评估外体PIK3CB作为ESCC的潜在诊断和治疗点.
主要方法:
- 对ESCC患者血中外体PIK3CB水平的分析.
- 外体PIK3CB和外体PD-L1.1之间的相关性分析.
- 研究PIK3CB对PD-L1促进剂活性和EMT标记物 (β-catenin,claudin-1) 的影响.
- 在PIK3CB调节后评估ESCC细胞迁移,干细胞和瘤生长.
主要成果:
- 在ESCC患者中检测到异位体PIK3CB升高,与预后不佳相关.
- 外体PIK3CB与外体PD-L1正相关,并促进了PD-L1的转录.
- 外体PIK3CB的下调降低了ESCC中的EMT,细胞迁移,干细胞和瘤生长.
结论:
- 外体PIK3CB通过增强PD-L1表达和促进恶性转变,在ESCC中充当瘤基因.
- 外体PIK3CB是ESCC预后的潜在生物标志物.
- 向外体PIK3CB为ESCC诊断和治疗提供了一个有前途的战略.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K